Literatur
-
1
Ruckman R N.
Cardiac causes of syncope.
Pediatr Rev.
1987;
9
101-108
-
2
Steinberg L A, Knilans T K.
Syncope in children: diagnostic tests have a high cost and low yield.
J Pediatr.
2005;
146
355-358
-
3 Fenrich A L, Denfield S W, Garson A. Sudden death in children.. In: Akhtar M, Myerburg R I, Ruskin JN Sudden Cardiac Death: Prevalence, mechanisms and approaches to diagnosis and management.. Philadelphia: Williams & Wilkins; 1994
-
4 Weissler A M, Warren J V. Syncope: pathophysiology and differenzial diagnosis.. In: J. W. Hurst, Logue R.B., Rackley C.E., et al., eds The heart.. New York: Mc Graw Hill; 1986: 507-529
-
5
Sra J S, Murthy V, Natale A, Jazayeri M R et al.
Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope.
Am J Cardiol..
1994;
73
33-37
-
6
Biffi M, Boriani G, Sabbatani P et al.
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.
Heart..
1997;
77
268-272
-
7
Grubb B P, Temesy-Armos P, Moore J et al.
Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome.
Am J Cardiol..
1992;
69
904-908
-
8
Alehan D, Celiker A, Ozme S.
Head-up tilt test: a highly sensitive, specific test for children with unexplained syncope.
Pediatr Cardiol..
1996;
17
86-90
-
9
Kenny R A, Ingram A, Bayliss J, Sutton R.
Head-up tilt: a useful test for investigating unexplained syncope.
Lancet..
1986;
1
1352-1355
-
10
Levine M M.
Neurally mediated syncope in children: results of tilt testing, treatment, and long-term follow-up.
Pediatr Cardiol..
1999;
20
331-335
-
11
Alehan D, Lenk M, Ozme S et al.
Comparison of sensitivity and specificity of tilt protocols with and without isoproterenol in children with unexplained syncope.
Pacing Clin Electrophysiol..
1997;
20
1769-1776
-
12
Sheldon R, Splawinski J, Killam S.
Reproducibility of isoproterenol tilt-table tests in patients with syncope.
Am J Cardiol..
1992;
69
1300-1305
-
13
Fitzpatrick A P, Theodorakis G, Vardas P, Sutton R.
Methodology of head-up tilt testing in patients with unexplained syncope.
J Am Coll Cardiol..
1991;
17
125-130
-
14
Schmidt V, Kienast W, Lenschow U, Bartolomaeus G.
Kipptischuntersuchung. Wertigkeit bei der Diagnostik unklarer Synkopen im Kindes- und Jugendalter.
Monatsschr Kinderheilkd.
2000;
262-267
-
15
Grubb B P, Klingenheben T.
[Postural orthostatic tachycardia syndrome (POTS): etiology, diagnosis and therapy].
Med Klin (Munich).
2000;
95
442-446
-
16
Batra A S, Balaji S.
Usefulness of tilt testing in children with syncope: a survey of pediatric electrophysiologists.
Indian Pacing Electrophysiol J..
2008;
8
242-246
-
17
Blucher S, Kaemmerer H, Lammers A et al.
Event recorder for etiological evaluation of sporadically occurring cardiovascular complaints and symptoms.
Herz.
2000;
25
643-650
-
18
Klingenheben T, Kalusche D, Li Y G et al.
Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists.
J Cardiovasc Electrophysiol..
1996;
7
802-808
-
19
Grubb B P, Samoil D, Kosinski D et al.
Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.
J Am Coll Cardiol..
1994;
24
490-494
-
20
Lenk M, Alehan D, Ozme S et al.
The role of serotonin re-uptake inhibitors in preventing recurrent unexplained childhood syncope – a preliminary report.
Eur J Pediatr..
1997;
156
747-750
-
21
Massin M.
Neurocardiogenic syncope in children: current concepts in diagnosis and management.
Paediatr Drugs..
2003;
5
327-334
-
22
Qingyou Z, Junbao D, Chaoshu T.
The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.
J Pediatr..
2006;
149
777-780
-
23
Jacob G, Shannon J R, Black B et al.
Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia.
Circulation..
1997;
96
575-580
-
24
Salim M A, Di Sessa T G.
Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial.
J Am Coll Cardiol..
2005;
45
484-488
-
25
Ross R, Parry S, Norton M, Newton J L.
Self-reported symptom burden; outcome in 418 patients from the Newcastle Vasovagal (Neurocardiogenic) cohort.
Qjm..
2008;
101
127-135
Dr. Kai Thorsten Laser
HDZ-NRW
Zentrum für Angeborene Herzfehler
Georgstr. 11
32545 Bad Oynhausen
